Chlamydia trachomatis (Ct) can induce scarring disease of the ocular mucosa, known as trachoma, the most common infectious cause of blindness worldwide. We hypothesized that epithelial-mesenchymal transition (EMT) contributes to the fibrotic process in trachomatous scarring. Infection of human conjunctival epithelial cells (HCjE) with Ct activated signaling pathways involved in EMT induction, which was correlated with decreased expression of E-cadherin, guardian of the epithelial phenotype. In addition, Ct infection was associated with increased expression of two mesenchymal cell markers: fibronectin and α-SMA. The DNA methylation statuses of selected regions of E-cadherin, fibronectin, and α-SMA genes revealed that Ct infection was accompanied with changes in DNA methylation of the E-cadherin promoter, while the expression of the two mesenchymal markers was not related with this epigenetic event. Our data suggest that Ct infection of conjunctival epithelial cells induces EMT-like changes that go along with modification of the methylation profile of the E-cadherin promoter and could, as one of the earliest events, contribute to processes triggering conjunctival scarring.
Chlamydia trachomatis Infection Is Associated with E-Cadherin Promoter Methylation, Downregulation of E-Cadherin Expression, and Increased Expression of Fibronectin and α-SMA-Implications for Epithelial-Mesenchymal Transition.
沙眼衣原体感染与 E-钙黏蛋白启动子甲基化、E-钙黏蛋白表达下调以及纤连蛋白和α-SMA表达增加有关——对上皮-间质转化的影响
阅读:5
作者:RajiÄ Jovana, Inic-Kanada Aleksandra, Stein Elisabeth, DiniÄ Svetlana, Schuerer Nadine, UskokoviÄ Aleksandra, Ghasemian Ehsan, MihailoviÄ Mirjana, VidakoviÄ Melita, GrdoviÄ Nevena, Barisani-Asenbauer Talin
| 期刊: | Frontiers in Cellular and Infection Microbiology | 影响因子: | 4.800 |
| 时间: | 2017 | 起止号: | 2017 Jun 14; 7:253 |
| doi: | 10.3389/fcimb.2017.00253 | 研究方向: | 表观遗传 |
| 信号通路: | DNA甲基化 | ||
特别声明
1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。
2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。
3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。
4、投稿及合作请联系:info@biocloudy.com。
